Has Your Business Outgrown Its AML Program? What Broker-Dealers Should Review

Key Question

Can your broker-dealer demonstrate that its AML controls work in practice?

Our View

Broker-dealers, compliance officers, and senior management should assess whether their anti-money laundering programs reflect actual business risks, link relevant customer and transaction information, and produce documented evidence that they identify, investigate, and appropriately resolve potentially suspicious activity.

Executive Summary

FINRA’s October 6, 2026 settlement announcement and accompanying Letter of Acceptance, Waiver and Consent (AWC) concerning Revere Securities LLC offer a practical reminder that a broker-dealer’s anti-money laundering (AML) program must operate effectively in the business it actually conducts. FINRA fined Revere $800,000 for AML and supervisory failures associated with foreign-based small-cap initial public offerings and required an independent consultant review and remediation. Revere consented to FINRA’s findings without admitting or denying them. The matter applies existing requirements; it does not establish a new industrywide AML rule or deadline.

Although the enforcement action focused on small-cap offerings, the underlying issues, including customer identification, risk-based monitoring, cross-functional escalation, and documented decisions, matter to all broker-dealers. Firms should therefore use the action to test whether their written programs and day-to-day practices address their customers, products, transactions, and relationships.

Regulatory Background

FINRA Rule 3310 requires each member firm to establish and implement a written AML program reasonably designed to achieve and monitor compliance with the Bank Secrecy Act and implementing regulations. The program must address suspicious transaction detection and reporting, internal controls, designated AML responsibility, ongoing training, and independent testing, and must receive senior management’s written approval. Rule 3310 also requires risk-based ongoing customer due diligence, including understanding the nature and purpose of customer relationships and monitoring for suspicious transactions. The precise controls should reflect the firm’s activities rather than a generic checklist.

The customer identification program rule, 31 C.F.R. § 1023.220, requires risk-based identity verification procedures that enable a broker-dealer to form a reasonable belief that it knows each customer’s true identity. Procedures must address circumstances in which verification fails, including decisions on whether to open or close an account, whether transactions may proceed, and whether to consider a suspicious activity report. Verifying identity is distinct from assessing the legitimacy of a relationship or subsequent activity; both may inform an effective AML review.

Under 31 C.F.R. § 1023.320, a broker-dealer generally must report qualifying suspicious transactions conducted or attempted by, at, or through the firm that involve at least $5,000 in aggregate, where the rule’s grounds for suspicion are present, subject to applicable exceptions. Proof of criminal conduct is not required. A firm should therefore avoid investigation standards that delay a reporting decision until wrongdoing is conclusively established.

What the Revere Settlement Reveals About AML Supervision

    Customer Information Must Support Meaningful Review. FINRA reported that seemingly unrelated customers opened accounts on the same dates, used common residential addresses, and later exhibited similar trading patterns. In one IPO, Revere allocated more than $1.5 million in shares to eight customers referred by a foreign broker-dealer. Four applicants reported being unemployed while claiming annual incomes exceeding $200,000; seven applications contained contradictory source-of-funds information. All eight later emailed same-day liquidation instructions from IP addresses traceable to countries other than those of their reported residences. FINRA found that the firm failed to identify these factors as potentially suspicious. See the FINRA announcement and AWC. None of these characteristics alone establishes misconduct. Shared addresses, common introductions, or unusual trading may have legitimate explanations. The control question is whether personnel recognize when facts warrant further inquiry, examine related information, and record a supportable disposition rather than treating account-opening fields as sufficient merely because they are completed.

    The Lessons Extend Beyond Small-Cap Offerings. Although FINRA’s findings concern a specific small-cap IPO, the underlying AML obligations apply across the broker-dealer industry. Retail brokerage firms may encounter unusual funding, withdrawals, or coordinated trading; institutional firms and placement agents may face risks related to investor introductions, transaction structures, foreign counterparties, or payment instructions. Each firm’s exposure varies, but the obligation to maintain a reasonably designed AML program does not depend on participation in small-cap offerings. This broader application is a compliance implication of existing rules, not an assertion that FINRA made findings about unrelated business models. The common supervisory issue is whether the firm connects the information it possesses, assigns responsibility for reviewing concerns, and can demonstrate that its decisions were timely and reasonable.

    Departments Need a Defined Escalation Process. An investment banking team may know who introduced an investor; account-opening personnel may notice conflicting financial information; operations may see unusual payment instructions; and trading personnel may observe synchronized transactions. Each observation may seem less significant in isolation. Firms should define when and how these observations reach the AML officer, identify escalation owners and backups, and document the outcome. Smaller firms need the same clarity, even when a single employee performs several functions.

    Surveillance Must Reflect Observable Business Risks. FINRA Regulatory Notice 19-18 provides illustrative indicators of suspicious activity and emphasizes that firms should tailor monitoring to their business rather than assume every indicator applies universally. For example, a private placement firm may evaluate inconsistencies among subscriptions, introductions, and funding instructions; a trading-focused firm may examine patterns across related accounts and transactions. These are practical applications of existing AML principles, not additional findings in the Revere action. FINRA’s October 2025 small-cap offerings sweep letter reinforces the need to examine how business activity interacts with controls. The targeted information requests cover AML programs, securities-trading supervisory procedures, monitoring tools, account opening, money movements, and initial allocation and secondary-market trading. That sweep focuses on a defined market segment and should not be described as an industrywide examination; however, its integrated review approach offers a useful model for other firms. Introducing firms should likewise understand their clearing arrangements, information flows, exception reporting, and responsibility for investigating suspicious activity.

Recommended Actions

Broker-dealers should conduct a focused, risk-based review of the relationship between current operations and AML procedures. The following steps are recommended implementation measures, not new requirements imposed by the Revere settlement:

  • Compare the Program With Current Business. Identify changes in customer locations, offerings, referral sources, funding methods, transaction volumes, and third-party relationships since the last meaningful program review. Map each material risk to the available information, the control addressing it, and the employee responsible. Revise procedures that describe discontinued activities or omit growing business lines.
  • Test Detection as Well as Investigative Quality. Sample recent accounts and transactions to present relevant indicators, and trace each matter from identification through escalation, investigation, and closure. Review selected closed alerts for the adequacy of explanations and selected activity that generated no alert for potential detection gaps. Closing every generated alert does not establish that the program detects activity it should identify.
  • Document Reporting Decisions and Deadlines. Records should include the concern, dates, supporting facts, the reviewer responsible, investigative steps, and the rationale for the disposition. The SAR rule generally requires filing within 30 calendar days of the initial detection of facts that may constitute a basis for filing, with a limited extension if no suspect is identified. Firms should track applicable deadlines, protect SAR confidentiality, and retain required records and supporting documentation.
  • Give Management Useful Results. Provide management with meaningful information on recurring exceptions, overdue investigations, unresolved risks, and remediation progress—not just alert counts. Tailor training specific to each department to the warning signs personnel are likely to encounter. Independent testing should assess whether controls operate as designed, including how information flows across functions; firms should confirm the testing frequency applicable under Rule 3310.

Key Takeaways

The Revere settlement underscores that effective AML compliance depends not only on having appropriate written procedures but also on ensuring those procedures address the firm’s actual business risks and operate effectively in practice. Three key takeaways apply to all broker-dealers, regardless of their business model or involvement in small-cap offerings.

  • Industrywide relevance – The Revere action concerns small-cap IPOs, but the underlying AML lessons apply to broker-dealers with different business models; controls must address each firm’s actual risks.
  • Connected review – Customer information, referral relationships, funding activity, and trading patterns should be considered together when circumstances warrant, with clear escalation responsibility.
  • Documented effectiveness – Firms should preserve the basis for investigative and reporting decisions and test both alert resolution and whether relevant activity is being detected.

Conclusion

The Revere settlement does not create a new AML standard, but it provides a concrete opportunity for all broker-dealers to test whether their existing programs are effective in practice. A program should evolve with the firm’s business, connect information across functions, and produce defensible records of investigations and reporting decisions. Firms should prioritize gaps that prevent relevant concerns from reaching responsible personnel and verify that remediation improves actual performance.

Call to Action

Contact The LeGaye Law Group for assistance evaluating AML program effectiveness, updating supervisory procedures, assessing escalation and investigation practices, and developing business-specific training and testing.